SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
14679122
Source:
http://linkedlifedata.com/resource/pubmed/id/14679122
Search
Subject
(
60
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0014852
,
umls-concept:C0030705
,
umls-concept:C0123931
,
umls-concept:C0205179
,
umls-concept:C0282460
,
umls-concept:C0699791
,
umls-concept:C2347678
pubmed:issue
1
pubmed:dateCreated
2003-12-17
pubmed:abstractText
The purpose of this study was to assess the efficacy and toxicity of irinotecan and 5-fluorouracil (5-FU) in primary refractory or relapsed locally advanced or metastatic oesophagogastric (O-G) carcinoma.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9007735
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Camptothecin
,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil
,
http://linkedlifedata.com/resource/pubmed/chemical/Leucovorin
,
http://linkedlifedata.com/resource/pubmed/chemical/irinotecan
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0923-7534
pubmed:author
pubmed-author:AssersohnLL
,
pubmed-author:BrownGG
,
pubmed-author:CunninghamDD
,
pubmed-author:HillM EME
,
pubmed-author:NormanA RAR
,
pubmed-author:OatesJJ
,
pubmed-author:WardCC
,
pubmed-author:WatersJ SJS
pubmed:issnType
Print
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
64-9
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:14679122-Adenocarcinoma
,
pubmed-meshheading:14679122-Adult
,
pubmed-meshheading:14679122-Aged
,
pubmed-meshheading:14679122-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:14679122-Camptothecin
,
pubmed-meshheading:14679122-Carcinoma, Squamous Cell
,
pubmed-meshheading:14679122-Drug Administration Schedule
,
pubmed-meshheading:14679122-Esophageal Neoplasms
,
pubmed-meshheading:14679122-Female
,
pubmed-meshheading:14679122-Fluorouracil
,
pubmed-meshheading:14679122-Humans
,
pubmed-meshheading:14679122-Leucovorin
,
pubmed-meshheading:14679122-Male
,
pubmed-meshheading:14679122-Middle Aged
,
pubmed-meshheading:14679122-Neoplasm Recurrence, Local
,
pubmed-meshheading:14679122-Stomach Neoplasms
,
pubmed-meshheading:14679122-Treatment Outcome
pubmed:year
2004
pubmed:articleTitle
Phase II study of irinotecan and 5-fluorouracil/leucovorin in patients with primary refractory or relapsed advanced oesophageal and gastric carcinoma.
pubmed:affiliation
Royal Marsden Hospital, London and Sutton, Surrey, UK.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Clinical Trial, Phase II